<SEC-DOCUMENT>0001209191-20-061823.txt : 20201204
<SEC-HEADER>0001209191-20-061823.hdr.sgml : 20201204
<ACCEPTANCE-DATETIME>20201204170341
ACCESSION NUMBER:		0001209191-20-061823
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20201201
FILED AS OF DATE:		20201204
DATE AS OF CHANGE:		20201204

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			WITTY ANDREW
		CENTRAL INDEX KEY:			0001711304

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10864
		FILM NUMBER:		201370550

	MAIL ADDRESS:	
		STREET 1:		79 TW ALEXANDER DRIVE
		STREET 2:		4501 RESEARCH COMMONS, SUITE 100
		CITY:			RESEARCH TRIANGLE PARK
		STATE:			NC
		ZIP:			27709

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UNITEDHEALTH GROUP INC
		CENTRAL INDEX KEY:			0000731766
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				411321939
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		UNITEDHEALTH GROUP CENTER
		STREET 2:		9900 BREN ROAD EAST
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55343
		BUSINESS PHONE:		9529361300

	MAIL ADDRESS:	
		STREET 1:		9900 BREN ROAD EAST
		CITY:			MINNETONKA
		STATE:			MN
		ZIP:			55343

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP/
		DATE OF NAME CHANGE:	20000309

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	UNITED HEALTHCARE CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc3.xml
<DESCRIPTION>FORM 3 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2020-12-01</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000731766</issuerCik>
        <issuerName>UNITEDHEALTH GROUP INC</issuerName>
        <issuerTradingSymbol>UNH</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001711304</rptOwnerCik>
            <rptOwnerName>WITTY ANDREW</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O UNITEDHEALTH GROUP</rptOwnerStreet1>
            <rptOwnerStreet2>9900 BREN ROAD EAST</rptOwnerStreet2>
            <rptOwnerCity>MINNETONKA</rptOwnerCity>
            <rptOwnerState>MN</rptOwnerState>
            <rptOwnerZipCode>55343</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>President, UHG &amp; CEO, Optum</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>58629.624</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>244.43</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2028-06-05</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>23548</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>262.98</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2029-02-26</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>38078</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>250.52</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2029-11-06</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>17845</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Non-Qualified Stock Option (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>302.20</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F5"/>
            </exerciseDate>
            <expirationDate>
                <value>2030-02-13</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>50817</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Amount does not include Performance Share Awards granted to the executive officer on June 5, 2018, February 26, 2019, November 6, 2019 and February 13, 2020, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance periods and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target numbers of Performance Shares are 17,183, 18,063, 5,988 and 17,704 for the February 2018, February 2019, November 19 and February 2020 grants, respectively.</footnote>
        <footnote id="F2">The original stock option grant of 47,096 shares began vesting annually at a rate of 25% on each anniversary of June 5, 2018, the original grant date.</footnote>
        <footnote id="F3">The original stock option grant of 50,770 shares began vesting annually at a rate of 25% on each anniversary of February 26, 2019, the original grant date.</footnote>
        <footnote id="F4">This stock option grant began vesting annually at a rate of 25% on each anniversary of November 6, 2019, the original grant date.</footnote>
        <footnote id="F5">This stock option grant vests at a rate of 25% annually on each anniversary of February 13 from the years 2021 through 2024.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>Faraz A. Choudhry, Attorney-in-Fact for Andrew P. Witty</signatureName>
        <signatureDate>2020-12-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>attachment1.htm
<DESCRIPTION>EX-24 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
POWER OF ATTORNEY


The undersigned, Andrew P. Witty, hereby authorizes and designates
each of Marianne D. Short, Dannette L. Smith, and Faraz Choudhry,
or any of them, acting singly with full power of substitution (each, an
"attorney-in-fact"), to sign and file on the undersigned's behalf the
Form ID in order to obtain or manage EDGAR filing codes, and any Forms
3, 4, 5 or 144 (including any amendments thereto) that the undersigned
may be required to file with the Securities and Exchange Commission as
a result of the undersigned's ownership of or transactions in securities
of UnitedHealth Group Incorporated (the "Company") at any date following
the date hereof. The authority of each attorney-in-fact under this Power
of Attorney will continue until the undersigned is no longer required to
file Forms 3, 4, 5 and 144 with regard to the undersigned's ownership of
or transactions in securities of the Company, unless earlier revoked in
writing.  The undersigned hereby revokes all previous powers of attorney to
sign or file on the undersigned's behalf any Forms 3, 4, 5 or 144
with regard to Company securities as of the date hereof, except that
if the undersigned has adopted any Rule 10b5-1 trading plan to transact
in Company securities, any powers of attorney the undersigned may have
granted under the plan to sign or file on the undersigned's behalf any
Form 144 shall continue to be in full force and effect in accordance
with the terms of the plan. The undersigned acknowledges that neither
the Company nor an attorney-in-fact is assuming any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act
of 1934 or Rule 144 under the Securities Act of 1933.


Date: July 24, 2017

Andrew P. Witty

</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
